TLC Submits IND Application In Taiwan For TLC19 Inhalable Liposomal Hydroxychloroquine For COVID-19

Taiwanese specialty pharmaceutical company Taiwan Liposome Co. Ltd. (TLC) announced Friday the submission of an Investigational New Drug (IND) Application to the Taiwan Food and Drug Administration …
( read original story …)


Search your Hotel